Journal article
Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD
PLoS genetics, Vol.12(8), pp.e1006011-e1006011
08/2016
DOI: 10.1371/journal.pgen.1006011
PMCID: PMC4988780
PMID: 27532455
Abstract
Implementing precision medicine for complex diseases such as chronic obstructive lung disease (COPD) will require extensive use of biomarkers and an in-depth understanding of how genetic, epigenetic, and environmental variations contribute to phenotypic diversity and disease progression. A meta-analysis from two large cohorts of current and former smokers with and without COPD [SPIROMICS (N = 750); COPDGene (N = 590)] was used to identify single nucleotide polymorphisms (SNPs) associated with measurement of 88 blood proteins (protein quantitative trait loci; pQTLs). PQTLs consistently replicated between the two cohorts. Features of pQTLs were compared to previously reported expression QTLs (eQTLs). Inference of causal relations of pQTL genotypes, biomarker measurements, and four clinical COPD phenotypes (airflow obstruction, emphysema, exacerbation history, and chronic bronchitis) were explored using conditional independence tests. We identified 527 highly significant (p < 8 X 10-10) pQTLs in 38 (43%) of blood proteins tested. Most pQTL SNPs were novel with low overlap to eQTL SNPs. The pQTL SNPs explained >10% of measured variation in 13 protein biomarkers, with a single SNP (rs7041; p = 10-392) explaining 71%-75% of the measured variation in vitamin D binding protein (gene = GC). Some of these pQTLs [e.g., pQTLs for VDBP, sRAGE (gene = AGER), surfactant protein D (gene = SFTPD), and TNFRSF10C] have been previously associated with COPD phenotypes. Most pQTLs were local (cis), but distant (trans) pQTL SNPs in the ABO blood group locus were the top pQTL SNPs for five proteins. The inclusion of pQTL SNPs improved the clinical predictive value for the established association of sRAGE and emphysema, and the explanation of variance (R2) for emphysema improved from 0.3 to 0.4 when the pQTL SNP was included in the model along with clinical covariates. Causal modeling provided insight into specific pQTL-disease relationships for airflow obstruction and emphysema. In conclusion, given the frequency of highly significant local pQTLs, the large amount of variance potentially explained by pQTL, and the differences observed between pQTLs and eQTLs SNPs, we recommend that protein biomarker-disease association studies take into account the potential effect of common local SNPs and that pQTLs be integrated along with eQTLs to uncover disease mechanisms. Large-scale blood biomarker studies would also benefit from close attention to the ABO blood group.
Details
- Title: Subtitle
- Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD
- Creators
- Alejandro Comellas - Division of Pulmonary and Critical Care Medicine, University of Iowa, Iowa City, Iowa, United States of AmericaWei Sun - Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of AmericaKaterina Kechris - Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of AmericaEric A Hoffman - Department of Radiology, Division of Physiologic Imaging, University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States of AmericaSean Jacobson - National Jewish Health, Denver, Colorado, United States of AmericaM Bradley Drummond - Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of AmericaGregory A Hawkins - Center for Genomics and Personalized Medicine Research, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States of AmericaJenny Yang - Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of AmericaTing-Huei Chen - Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of AmericaPedro Miguel Quibrera - Collaborative Studies Coordinating Center, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of AmericaWayne Anderson - Marsico Lung Institute/Cystic Fibrosis Research Center, Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina United States of AmericaR Graham Barr - Department of Medicine, Columbia University Medical Center, New York, New York; Department of Epidemiology, Mailman School of Public Health at Columbia University, New York, New York, United States of AmericaPatricia V Basta - Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of AmericaEugene R Bleecker - Center for Genomics and Personalized Medicine Research, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States of AmericaTerri Beaty - Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University,Baltimore, Maryland, United States of AmericaRichard Casaburi - Division of Respiratory and Critical Care Physiology and Medicine, Harbor- University of California at Los Angeles Medical Center, Torrance, California, United States of AmericaPeter Castaldi - Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of AmericaMichael H Cho - Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of AmericaJames D Crapo - Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, Denver, Colorado, United States of AmericaGerard Criner - Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States of AmericaDawn Demeo - Division of Pulmonary and Critical Care Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of AmericaStephanie A Christenson - Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of San Francisco Medical Center, University of California San Francisco, San Francisco, California, United States of AmericaDavid J Couper - Collaborative Studies Coordinating Center, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of AmericaJeffrey L Curtis - Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, Michigan; VA Ann Arbor Healthcare System, Ann Arbor, Michigan, United States of AmericaClaire M Doerschuk - Marsico Lung Institute/Cystic Fibrosis Research Center, Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina United States of AmericaChristine M Freeman - Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, Michigan; VA Ann Arbor Healthcare System, Ann Arbor, Michigan, United States of AmericaNatalia A Gouskova - Collaborative Studies Coordinating Center, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of AmericaMeiLan K Han - Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, Michigan, United States of AmericaNicola A Hanania - Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, Texas, United States of AmericaNadia N Hansel - Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of AmericaCraig P Hersh - Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of AmericaRobert J Kaner - Department of Genetic Medicine, Weill Cornell Medical College, New York, New York, Department of Medicine, Division of Pulmonary and Critical Care Medicine, Weill Cornell Medical College, New York, New York, United States of AmericaRichard E Kanner - Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Utah, Salt Lake City, Utah, United States of AmericaEric C Kleerup - Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of AmericaSharon Lutz - Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of AmericaFernando J Martinez - Department of Medicine, Weill Cornell Medical College, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, New York, United States of AmericaDeborah A Meyers - Center for Genomics and Personalized Medicine Research, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States of AmericaStephen P Peters - Department of Medicine, Division of Pulmonary, Critical Care, Allergy and Immunologic Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States of AmericaElizabeth A Regan - Department of Medicine, National Jewish Health, Denver, Colorado United States of AmericaStephen I Rennard - Division of Pulmonary and Critical Care Medicine, University of Nebraska, Omaha, Nebraska, United States of AmericaMary Beth Scholand - Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Utah, Salt Lake City, Utah, United States of AmericaEdwin K Silverman - Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of AmericaPrescott G Woodruff - Division of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine and Cardiovascular Research Institute, University of California San Francisco School of Medicine, San Francisco, California, United States of AmericaWanda K O'Neal - Marsico Lung Institute/Cystic Fibrosis Research Center, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina United States of AmericaRussell P Bowler - Department of Medicine, Division of Pulmonary Medicine, National Jewish Health, Denver, Colorado, United States of AmericaCOPDGene Investigators
- Resource Type
- Journal article
- Publication Details
- PLoS genetics, Vol.12(8), pp.e1006011-e1006011
- DOI
- 10.1371/journal.pgen.1006011
- PMID
- 27532455
- PMCID
- PMC4988780
- NLM abbreviation
- PLoS Genet
- ISSN
- 1553-7390
- eISSN
- 1553-7404
- Publisher
- Public Library Science
- Grant note
- HHSN268200900017C / NHLBI NIH HHS P30 ES005605 / NIEHS NIH HHS HHSN268200900019C / NHLBI NIH HHS HHSN268200900020C / NHLBI NIH HHS U01 HL089897 / NHLBI NIH HHS R01 HL089856 / NHLBI NIH HHS HHSN268200900015C / NHLBI NIH HHS P30 CA015704 / NCI NIH HHS HHSN268200900013C / NHLBI NIH HHS R01 HL124233 / NHLBI NIH HHS UL1 RR025780 / NCRR NIH HHS HHSN268200900016C / NHLBI NIH HHS R01 HL125432 / NHLBI NIH HHS U01 HL089856 / NHLBI NIH HHS K01 HL125858 / NHLBI NIH HHS HHSN268200900018C / NHLBI NIH HHS HHSN268200900014C / NHLBI NIH HHS P30 ES010126 / NIEHS NIH HHS T32 ES007142 / NIEHS NIH HHS R01 HL089897 / NHLBI NIH HHS P30 DK054759 / NIDDK NIH HHS K12 HL119997 / NHLBI NIH HHS
- Language
- English
- Date published
- 08/2016
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Radiology; Pulmonary, Critical Care, and Occupational Medicine; ICTS; Internal Medicine
- Record Identifier
- 9984094357902771
Metrics
13 Record Views